- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Jenburkt Pharmaceuticals Ltd — Board Meeting, 06-08-2026: Board Meeting
06-08-2026 | 07:59 pm
06-08-2026 | 07:59 pm
Jenburkt Pharma's board approved Q1 FY27 financial results. Revenue from operations reached ₹35.51 Cr, while Profit After Tax was ₹5.89 Cr. EPS stood at ₹13.34.
No comments yet. Be the first to comment!